キッズウェル・バイオ announced that it had executed a share subscription agreement for a joint investment in アルフェナックス バイオロジクス. The timely disclosure date was 9 November 2026.
On 9 November 2026, キッズウェル・バイオ announced that it had made available a disclosure document titled “Notice regarding the execution of a share subscription agreement for a joint investment in アルフェナックス バイオロジクス株式会社.”
The disclosure announces the execution of a share subscription agreement for the purpose of making a joint investment in アルフェナックス バイオロジクス株式会社.